Replimune Group, Inc – a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies – ...

Pakistan PM Shehbaz Sharif reviewed safety measures for Chinese citizens in CPEC projects. China urged Pakistan to act ...

Savara faces an FDA setback for Molbreevi, its aPAP treatment. Learn how the company plans to recover and file a new BLA by ...

Replimune Group, Inc. faces FDA setbacks with RP1, raising financial risks and dilution concerns. Click here to find out why ...

The ongoing Monsoon Session of the Bihar Assembly witnessed another stormy session on Wednesday when Chief Minister Nitish Kumar called Leader of the Opposition Tejashwi Yadav ‘Bachcha’ (child) while ...

The ongoing Monsoon Session of Bihar Assembly witnessed another stormy session today when Chief Minister Nitish Kumar called Leader of Opposition in Bihar Assembly Tejashwi Yadav ‘Bachcha’ (a child) ...

Replimune faces FDA hurdles for RP1, an innovative melanoma treatment, as it seeks a path forward after receiving a complete ...

Sharif announced a slew of new security measures that his government will take to make Pakistan a business-friendly nation for Chinese nationals ...

During the event, DDC, in the presence of the other officers, distributed loan sanction letters under Mission YUVA among 42 ...

The Election Commission said on Tuesday that 26 lakh electors have shifted to different constituencies, while another seven lakh have enrolled at two places.

BMO Capital Markets pointed to FDA leadership, and CBER Director Vinay Prasad in particular, as potential factors in the ...

The FDA’s complete response letter cited concerns that the Phase I/II IGNYTE (CT03767348) trial in advanced melanoma was not ...